低危胸痛患者住院与负荷试验的必要性
本研究基于CHOPIN试验数据,纳入2071例急性胸痛患者,筛选出475例心电图正常且就诊时及2小时后肌钙蛋白I<0.040μg/l、和肽素<14pmol/l的低危患者进行进一步分析。475例低危患者180天随访期间(包括就诊时)无一例诊断为心肌梗死,阴性预测值100%(95%CI:99.2%-100.0%),且无死亡。低危组中287例(60.4%)住院,住院患者接受血运重建的比例更高(6.3% vs 0.5%,p=.002),接受负荷试验或血管造影的比例也更高(68.6% vs 22.9%,p<.001);接受检查者随访期间心脏再住院率更低(1.7% vs 5.1%,p=.040)。作者认为这些低危患者可考虑早期门诊检查和心内科随访,从而减少住院。
要点
- 心电图正常且就诊时及2小时后肌钙蛋白I<0.040μg/l、和肽素<14pmol/l的急性胸痛患者,180天内(含就诊时)无心肌梗死,阴性预测值100%(95%CI:99.2%-100.0%),无死亡。
- 低危组475例中287例(60.4%)仍住院,住院患者接受负荷试验或血管造影的比例显著高于未住院者(68.6% vs 22.9%,p<.001)。
- 低危组住院患者血运重建率高于未住院者(6.3% vs 0.5%,p=.002),但两组心肌梗死、死亡、心脏再住院等结局仅在再住院率上因是否接受检查而不同。
- 接受负荷试验或血管造影的低危患者随访期间心脏再住院率低于未接受检查者(1.7% vs 5.1%,p=.040)。
- 作者认为,符合上述低危标准的患者可考虑早期门诊检查和心内科随访,以减少住院。
适用人群与场景
- 急性胸痛患者,来自CHOPIN试验纳入的2071例患者。
- 低危亚组:心电图正常,且就诊时及2小时后肌钙蛋白I<0.040μg/l、和肽素<14pmol/l,共475例。
诊断标准与关键阈值
- 低危标准:心电图正常,肌钙蛋白I<0.040μg/l,和肽素<14pmol/l,且就诊时和2小时后均满足。
研究设计与关键结果
- 研究类型:基于CHOPIN试验数据的分析;低危组475例,180天随访期间(包括就诊时)无心肌梗死诊断,阴性预测值100%(95%CI:99.2%-100.0%),无死亡。
- 低危组287例(60.4%)住院;住院患者血运重建率6.3%(95%CI:3.8%-9.7%) vs 未住院者0.5%(95%CI:0.0%-2.9%),p=.002。
- 住院患者接受负荷试验或血管造影的比例68.6%(95%CI:62.9%-74.0%) vs 未住院者22.9%(95%CI:17.1%-29.6%),p<.001。
- 接受检查者随访期间心脏再住院率1.7% vs 未接受检查者5.1%,p=.040。
证据类型、等级与局限
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,心电图正常且就诊时及2小时后肌钙蛋白I<0.040μg/l、和肽素<14pmol/l的低危胸痛患者,可考虑早期门诊检查和心内科随访,以减少住院。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Copeptin is a marker of endogenous stress including early myocardial infarction(MI) and has value in early rule out of MI when used with cardiac troponin I(cTnI).
OBJECTIVES: The goal of this study was to demonstrate that patients with a normal electrocardiogram and cTnI<0.040μg/l and copeptin<14pmol/l at presentation and after 2 h may be candidates for early discharge with outpatient follow-up potentially including stress testing.
METHODS: This study uses data from the CHOPIN trial which enrolled 2071 patients with acute chest pain. Of those, 475 patients with normal electrocardiogram and normal cTnI(<0.040μg/l) and copeptin<14pmol/l at presentation and after 2 h were considered "low risk" and selected for further analysis.
RESULTS: None of the 475 "low risk" patients were diagnosed with MI during the 180day follow-up period (including presentation). The negative predictive value of this strategy was 100% (95% confidence interval(CI):99.2%-100.0%). Furthermore no one died during follow up. 287 (60.4%) patients in the low risk group were hospitalized. In the "low risk" group, the only difference in outcomes (MI, death, revascularization, cardiac rehospitalization) was those hospitalized underwent revascularization more often (6.3%[95%CI:3.8%-9.7%] versus 0.5%[95%CI:0.0%-2.9%], p=.002). The hospitalized patients were tested significantly more via stress testing or angiogram (68.6%[95%CI:62.9%-74.0%] vs 22.9%[95%CI:17.1%-29.6%], p<.001). Those tested had less cardiac rehospitalizations during follow-up (1.7% vs 5.1%, p=.040).
CONCLUSIONS: In conclusion, patients with a normal electrocardiogram, troponin and copeptin at presentation and after 2 h are at low risk for MI and death over 180days. These low risk patients may be candidates for early outpatient testing and cardiology follow-up thereby reducing hospitalization.
参考来源
- Beri N, Marston NA, Daniels LB, et al. Necessity of hospitalization and stress testing in low risk chest pain patients. Am J Emerg Med. 2016. PMID: 27847253. doi:10.1016/j.ajem.2016.10.072
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。